dc.contributor.author | Guida, Maurizio | |
dc.contributor.author | Marra, Marialuisa | |
dc.contributor.author | Palatucci, Valeria | |
dc.contributor.author | Pascale, Renato | |
dc.contributor.author | Visconti, Federica | |
dc.contributor.author | Zullo, Fulvio | |
dc.date.accessioned | 2013-04-03T12:47:29Z | |
dc.date.available | 2013-04-03T12:47:29Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Guida M, Marra ML, Palatucci V, Pascale R, Visconti F, Zullo F. Emergency contraception: an updated review. Translational Medicine @ UniSa 2011;1(1):271-294 | en_US |
dc.identifier.issn | 2239-9747 | en_US |
dc.identifier.uri | http://hdl.handle.net/10556/518 | |
dc.description.abstract | Emergency contraception is a common practice now. Many categories of drugs are marketed with modifications in dosage, in combination and even in the timing of administration. Recent re-analysis suggests that there is still no uniformity of opinion on the actual mechanism of action and this has often fueled the ethical controversy. This review analyzes the most common emergency contraception drugs: levonorgestrel, mifepristone and ulipristal acetate about their action underlining that the hormonal products, when used in emergency contraception, play different roles depending on the phase of the menstrual cycle during which they are administered.This review aims to examine rigorously the most accredited literature to verify if a evidence-based uniformity of opinions has been achieved about the biological effects of hormones administered after the sexual intercourse. | en_US |
dc.format.extent | P. 271-294 | en_US |
dc.language.iso | en | en_US |
dc.source | UniSa. Sistema Bibliotecario di Ateneo | en_US |
dc.subject | Emergency contraception | en_US |
dc.subject | Levonorgestrel | en_US |
dc.subject | Mifepristone | en_US |
dc.subject | Ulipristal acetate | en_US |
dc.title | Emergency contraception: an updated review | en_US |
dc.type | Article | en_US |